Just to give a perspective on this Hervaxx results and the significance of it.
As those of us who have been on this journey, we all know that every drug have a fixed patent life. After which, biosims will be able to come to market to compete against the original. Consider this. If biosims think it worthwhile to try and just get a small piece of the market from the original, what do you think it will be worth for a drug that can totally take over the whole market of another by being better, safer and cheaper?
And here, we are talking about Herceptin's multi-billion dollars market. And here, we are talking about just ONE drug candidate out of a potential myriads of drug candidates that IMU will have.
The above is how I see IMU now. It is going to be big. Really big. All in my very excited opinion only
Ann: Investor Webinar - Final HER-Vaxx Overall Survival Results, page-9
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.7¢ | $2.298M | 47.86M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1925982 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 3452098 | 12 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |